ResMed RMD Income Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $32.85M+6.9% | $32.44M+4.3% | $32.27M+1.7% | $32.12M-2.6% | $30.74M-7.9% | ||
| $5.99M— | $4.61M— | $4.17M— | $3.64M— | —— | ||
| -$18.55M+20.2% | -$14.07M-283% | -$15.81M-283% | -$10.3M-155% | -$23.24M— | ||
| $1.52B+15.7% | $1.49B+19.0% | $1.44B+29.2% | $1.4B+37.2% | $1.31B+37.0% | ||
| —— | —— | -$15.81M-283% | -$10.3M-155% | -$23.24M— | ||
| $46.9M+5.1% | $46.54M+3.6% | $45.83M+0.8% | $45.27M-2.7% | $44.61M-6.2% | ||
| $34.79M+560% | $23.29M+220% | $14.57M+145% | $4.11M+109% | -$7.56M+85.4% | ||
| —— | —— | —— | $0— | $0-100% | ||
| $297.27M— | —— | —— | —— | —— | ||
| $171.25M+4.5% | $130.46M-4.2% | $124.03M+27.0% | $90.96M-25.5% | $163.85M+38,362% | ||
| $64.78M-49.8% | $87.96M-39.5% | $83.13M-20.4% | $76.68M-42.9% | $128.99M+36.0% | ||
| $8.19M— | —— | —— | —— | —— | ||
| $105.39M+644% | -$22.3M-126% | -$85.06M-216% | -$82.63M-172% | -$19.38M-113% | ||
| $26.91M-2.1% | $34.6M+42.4% | $27.98M-26.6% | $28.48M-37.7% | $27.49M-49.8% | ||
| -$907.75M-8.6% | -$796.58M+22.5% | -$685.77M+38.7% | -$606.25M+45.8% | -$835.65M— | ||
| -$295.26M-162% | -$269.02M-136% | -$254.77M-115% | -$200.05M+25.8% | -$112.84M+58.2% | ||
| $1.89B+14.3% | $1.91B+29.7% | $1.88B+30.7% | $1.75B+25.0% | $1.65B+37.9% | ||
| —— | —— | —— | $6.28M-18.4% | $2.3M— | ||
| $600.05M+140% | $500.06M+122% | $400.03M+100.0% | $300.03M+100% | $250.02M+150% | ||
| $340.16M+12.0% | $330.63M+11.5% | $320.74M+10.7% | $310.88M+10.1% | $303.84M+9.9% | ||
| —— | —— | $139.77M+349% | $140.1M+4.0% | $21.22M-82.2% | ||
| —— | —— | $139.77M+362% | $139.25M+4.3% | $20.37M-82.3% | ||
| —— | —— | $11.82M+86.7% | $10.78M-30.0% | $1.44M-92.1% | ||
| $28.55M+282% | $10.47M+34.1% | $7.24M-30.6% | $6.42M-49.7% | $7.48M-38.7% | ||
| $135.74M+61.3% | $122.89M+45.3% | $114.99M+31.8% | $89.87M-9.6% | $84.16M-22.8% | ||
| $75.35M+4.7% | $76.94M+13.4% | $74.26M+22.8% | $74.44M+40.2% | $71.98M+47.2% | ||
| —— | $10M-98.2% | $10M-98.5% | $40M-95.2% | $335M-50.7% | ||
| $101.64M+15.1% | $98.97M+17.0% | $92.67M+13.2% | $91.66M+14.3% | $88.3M+12.2% | ||
| $2.11B+18.0% | $2.02B+16.4% | $1.95B+22.0% | $1.88B+25.9% | $1.79B+28.5% | ||
| $1.89B+17.4% | $1.82B+16.6% | $1.74B+23.0% | $1.69B+27.7% | $1.61B+32.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is ResMed's revenue?
- ResMed (RMD) generated $5.5B in revenue over the trailing twelve months, up 10.3% year over year.
- Is ResMed profitable?
- ResMed reported $1.5B in net income over the trailing twelve months, a 27.4% net margin.
- What are ResMed's profit margins?
- Gross margin is 61.6% and operating margin is 34.2%, with a 27.4% net margin.
- What is ResMed's earnings per share?
- ResMed's diluted EPS over the trailing twelve months is $10.37.
- Where does ResMed's income statement data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
